Kobe, Japan

Mari Kono

This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Sysmex Corporation. Active years: 2013.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mari Kono - Innovator in Blood Analysis Technology.

Introduction

Mari Kono is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of medical technology, particularly in blood analysis. Her innovative approach has led to advancements that enhance the understanding of lymphocyte populations in blood samples.

Latest Patents

Mari Kono holds a patent for a blood analyzer and blood analyzing method. This invention provides a solution for obtaining information regarding B lymphocytes and T lymphocytes without the need for fluorescence-labeled antibodies. The blood analyzer includes a blood specimen supplying portion, a sample preparation portion that prepares a measurement sample, a light source, and two detectors for fluorescence and scattered light. The information processing portion classifies lymphocytes based on the intensity of fluorescence and scattered light, allowing for the acquisition of valuable information regarding B-lymphocytes and T-lymphocytes.

Career Highlights

Mari Kono is associated with Sysmex Corporation, a leading company in the field of medical diagnostics. Her work has been instrumental in developing technologies that improve blood analysis processes. She has demonstrated a commitment to advancing healthcare through her innovative inventions.

Collaborations

Some of her notable coworkers include Shoichiro Asada and Yuri Takagi. Their collaboration has contributed to the success of various projects within Sysmex Corporation.

Conclusion

Mari Kono's contributions to blood analysis technology exemplify her dedication to innovation in the medical field. Her patent for a blood analyzer represents a significant advancement in understanding lymphocyte populations, which can have a profound impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…